Loading company…
Wuhan Luting Biotechnology develops gene therapy drug delivery vectors, focusing on muscle aging-related diseases.
Founded in 2024 and based in Wuhan, China, Wuhan Luting Biotechnology researches and develops gene therapy drug delivery vectors. Its work focuses on gene therapy drugs for muscle aging-related diseases. In March 2026, the company raised venture funding from Wuchuang Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in